These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37503416)

  • 1. Retracted: Effect of Roxadustat on Factors Associated with Renal Fibrosis and Efficacy.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9753471. PubMed ID: 37503416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retracted: Efficacy and Mechanism of Roxadustat plus Oral Iron in the Treatment of Elderly Chronic Kidney Disease with Anemia.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9823823. PubMed ID: 37387946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Roxadustat on Factors Associated with Renal Fibrosis and Efficacy.
    Zheng F; Zhang P; Zhao M; Wang J; Xu X; Zhang C; Zhang L
    Comput Math Methods Med; 2022; 2022():4764254. PubMed ID: 35979053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retracted: Investigation on the Effect of Hemodialysis Combined with MDT Multimode Intervention on Renal Fibrosis Degree and Renal Function Improvement in Uremia Patients.
    Imaging CMM
    Contrast Media Mol Imaging; 2023; 2023():9840352. PubMed ID: 38075726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted: Exploring the Effect of Dapagliflozin on Alcoholic Kidney Injury and Renal Interstitial Fibrosis in Rats Based on TIMP-1/MMP-24 Pathway.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9830542. PubMed ID: 37387937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roxadustat: Not just for anemia.
    Zhu X; Jiang L; Wei X; Long M; Du Y
    Front Pharmacol; 2022; 13():971795. PubMed ID: 36105189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: Effects of Valsartan on LN, FN, MDA, Renal Tissue Fibrosis, and Inflammatory Infiltration in DN Rats.
    Imaging CMM
    Contrast Media Mol Imaging; 2023; 2023():9845738. PubMed ID: 37547644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: Poricoic Acid A Inhibits the NF-
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9863819. PubMed ID: 37868205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between blood concentration of roxadustat and clinical efficacy in patients with anemia of chronic kidney disease.
    Zhang Y; Jing Y; Zhou C
    Medicine (Baltimore); 2023 Apr; 102(15):e33564. PubMed ID: 37058012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retracted: Liuwei Dihuang Pill Attenuates Diabetic Nephropathy by Inhibiting Renal Fibrosis via TGF-
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9807184. PubMed ID: 37416191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of roxadustat in the treatment of renal allograft anemia patients: a case series.
    Li J; Ma K; Wang L; Qi H; Lv J; Rao Y; Peng W
    Ann Palliat Med; 2021 Nov; 10(11):11859-11867. PubMed ID: 34872310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of roxadustat in treatment of peritoneal dialysis patients with renal anaemia.
    Zhu XW; Zhang CX; Xu TH; Jiang GN; Yao L
    World J Clin Cases; 2021 Sep; 9(26):7682-7692. PubMed ID: 34621819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Roxadustat (Evrenzo
    Ugawa T; Ashizaki M; Murata A; Majikawa Y
    Nihon Yakurigaku Zasshi; 2021; 156(3):187-197. PubMed ID: 33952849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of efficacy of roxadustat and erythropoietin for the treatment of renal anemia in patients with chronic kidney disease: a retrospective study.
    Jin C; Zhang Y; Luo C; Ren Y; Ye B; Hu X; Li Y; Zhu B; He Q; Shao L
    Transl Androl Urol; 2022 Nov; 11(11):1568-1576. PubMed ID: 36507485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy, safety, and medication compliance of roxadustat on peritoneal dialysis patients with renal anemia affected by the COVID-19 pandemic: a retrospective study.
    Bao L; Bian X; Zhang A; Huang J; Ren L; Luo C
    Ann Palliat Med; 2022 Jun; 11(6):2017-2024. PubMed ID: 35817736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Roxadustat on anemia and residual renal function in patients new to peritoneal dialysis.
    Wu T; Qi Y; Ma S; Zhang L; Pu X; Chen K; Zhao Y; Sang S; Xiao J
    Ren Fail; 2022 Dec; 44(1):529-540. PubMed ID: 35318873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: Efficacy of Glucocorticoids and Glucocorticoid-Induced Hyperglycaemia in Renal Disease: A Meta-Analysis of Randomized Controlled Trials.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9827159. PubMed ID: 37416261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Effectiveness of Roxadustat in Dialysis-Dependent Patients With Renal Anemia: A Hospital-Based Cohort Study.
    Moussa O; Feng C; Wang JX; Li XS; Zhang FX; Tang XH
    Cureus; 2022 Apr; 14(4):e24427. PubMed ID: 35475244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: CT Imaging Characteristics and Influence Factors of Renal Dialysis-Associated Peritoneal Injury.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9761426. PubMed ID: 37860494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: Clinical Study on the Efficacy of Microwave Ablation (MA) in the Treatment of Stage I Renal Clear Cell Carcinoma by CT and MRI Imaging.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9862864. PubMed ID: 37476775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.